NCT03949374 Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients Status COMPLETED Phase PHASE4
NCT03885921 Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) Status COMPLETED Phase PHASE3
NCT03882996 A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) Status COMPLETED Phase PHASE3
NCT03882892 Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017) Status COMPLETED Phase PHASE3
NCT03881657 Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border Status COMPLETED Phase NA
NCT03872232 Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan Status COMPLETED Phase PHASE3
NCT03867318 Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030) Status COMPLETED Phase PHASE3
NCT03867110 An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013) Status COMPLETED Phase PHASE3
NCT03847974 Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 Status COMPLETED Phase PHASE2
NCT03830970 Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL Cholesterol Status COMPLETED Phase NA
NCT03815812 Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT03768427 Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) Status COMPLETED Phase PHASE3
NCT03739242 Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels Status COMPLETED Phase NA
NCT03718286 Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI Status COMPLETED Phase PHASE2
NCT03631238 The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions Status COMPLETED Phase N/A